ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Esperion Therapeutics Inc

Esperion Therapeutics Inc (ESPR)

2.555
0.035
( 1.39% )
Updated: 12:49:03

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 18.98M18.82M24.33M25.79M33.97M32.25M137.74M73.83M
Operating Income -41.62M-42.51M-48.61M-37.06M-27.53M-42.37M72.27M2.58M
Pre Tax Income -55.12M-55.49M-61.72M-49.94M-41.25M-56.34M61.02M-61.93M
Net Income -55.12M-55.49M-61.72M-49.94M-41.25M-56.34M61.02M-61.93M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -40.96M-41.16M-47.33M-35.4M-26.26M-41.29M75.05M5.03M
EBITDA -41.52M-42.42M-48.52M-37.01M-27.51M-42.36M72.27M2.59M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000148.36M227.55M78.45M75.48M116.33M
Operating Income -76.15M-168.98M-204.59M-93.1M-121.4M-226.73M-179.5M-155.56M
Pre Tax Income -74.98M-166.99M-201.81M-97.17M-143.55M-269.11M-233.66M-209.25M
Net Income -74.98M-166.99M-201.81M-97.17M-143.55M-269.11M-233.66M-209.25M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -3.324-6.348-7.523-3.534-5.143-4.28-3.133-1.84
EBIT -77.2M-169.29M-204.41M-92.75M-121.4M-222.76M-176.85M-150.27M
EBITDA -75.9M-168.72M-204.32M-92.78M-120.85M-226.12M-179M-155.4M

Your Recent History

Delayed Upgrade Clock